Abstract
Pneumolysin, an intracellular protein toxin of all clinically relevant pneumococcal serotypes, is released in vivo during the autolysis of pneumococci and is believed to pave the way for intact pneumococci to invade and cause disease. Therefore, antibodies to pneumolysin should prevent its destructive function. We measured antibodies to pneumococcal pneumolysin in acute- and convalescent-phase nasopharyngeal aspirate samples of 120 children (median age, 2.5 years) with acute otitis media by enzyme immunoassay. Nasopharyngeal immunoglobulin M (IgM) and IgG class antibodies to pneumolysin were rarely detectable, whereas IgA class antibody was detected often, occurred independently of serum IgA antibody in serum, and correlated with the presence of the secretory component in pneumococcal antibody, indicating local production of IgA antibodies. Nasopharyngeal IgA antibody to pneumolysin was detected in 93% of the children already in the acute phase of otitis. Twenty percent of the children developed at least a threefold rise in the pneumolysin-specific IgA antibody concentration by the convalescent phase of otitis, with the youngest at 6 months of age, regardless of the pneumococcal findings in the nasopharynx or middle ear fluid. We suggest that nasopharyngeal IgA antibody to pneumolysin can be produced early in life by pneumococcal colonization.
Full Text
The Full Text of this article is available as a PDF (216.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aniansson G., Alm B., Andersson B., Larsson P., Nylén O., Peterson H., Rignér P., Svanborg M., Svanborg C. Nasopharyngeal colonization during the first year of life. J Infect Dis. 1992 Jun;165 (Suppl 1):S38–S42. doi: 10.1093/infdis/165-supplement_1-s38. [DOI] [PubMed] [Google Scholar]
- Bluestone C. D., Stephenson J. S., Martin L. M. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992 Aug;11(8 Suppl):S7–11. doi: 10.1097/00006454-199208001-00002. [DOI] [PubMed] [Google Scholar]
- Boulnois G. J., Paton J. C., Mitchell T. J., Andrew P. W. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol. 1991 Nov;5(11):2611–2616. doi: 10.1111/j.1365-2958.1991.tb01969.x. [DOI] [PubMed] [Google Scholar]
- Du Clos T. W., Mold C., Paterson P. Y., Alroy J., Gewurz H. Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin Exp Immunol. 1981 Mar;43(3):565–573. [PMC free article] [PubMed] [Google Scholar]
- Faden H., Stanievich J., Brodsky L., Bernstein J., Ogra P. L. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J. 1990 Sep;9(9):623–626. [PubMed] [Google Scholar]
- Gray B. M., Converse G. M., 3rd, Dillon H. C., Jr Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 1980 Dec;142(6):923–933. doi: 10.1093/infdis/142.6.923. [DOI] [PubMed] [Google Scholar]
- Kanclerski K., Möllby R. Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J Clin Microbiol. 1987 Feb;25(2):222–225. doi: 10.1128/jcm.25.2.222-225.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karma P., Palva T., Kouvalainen K., Kärjä J., Mäkelä P. H., Prinssi V. P., Ruuskanen O., Launiala K. Finnish approach to the treatment of acute otitis media. Report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl. 1987 Mar-Apr;129:1–19. doi: 10.1177/00034894870960s201. [DOI] [PubMed] [Google Scholar]
- McDermott M. R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol. 1979 May;122(5):1892–1898. [PubMed] [Google Scholar]
- Mitchell T. J., Andrew P. W., Saunders F. K., Smith A. N., Boulnois G. J. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol. 1991 Aug;5(8):1883–1888. doi: 10.1111/j.1365-2958.1991.tb00812.x. [DOI] [PubMed] [Google Scholar]
- Paton J. C., Andrew P. W., Boulnois G. J., Mitchell T. J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol. 1993;47:89–115. doi: 10.1146/annurev.mi.47.100193.000513. [DOI] [PubMed] [Google Scholar]
- Paton J. C., Lock R. A., Hansman D. J. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun. 1983 May;40(2):548–552. doi: 10.1128/iai.40.2.548-552.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pichichero M. E., Hall C. B., Insel R. A. A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. J Clin Invest. 1981 May;67(5):1482–1489. doi: 10.1172/JCI110178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salo P., Närvänen A., Leinonen M. Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides. Infect Immun. 1993 Jul;61(7):2822–2826. doi: 10.1128/iai.61.7.2822-2826.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salo P., Ortqvist A., Leinonen M. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J Infect Dis. 1995 Feb;171(2):479–482. doi: 10.1093/infdis/171.2.479. [DOI] [PubMed] [Google Scholar]
- Taira S., Jalonen E., Paton J. C., Sarvas M., Runeberg-Nyman K. Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis. Gene. 1989 Apr 30;77(2):211–218. doi: 10.1016/0378-1119(89)90069-3. [DOI] [PubMed] [Google Scholar]
- Virolainen A., Salo P., Jero J., Karma P., Eskola J., Leinonen M. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol. 1994 Nov;32(11):2667–2670. doi: 10.1128/jcm.32.11.2667-2670.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]